Adc Therapeutics Sa Stock Buy Hold or Sell Recommendation
| ADCT Stock | USD 4.78 0.19 3.82% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ADC Therapeutics SA is 'Hold'. Macroaxis provides ADC Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ADCT positions. The advice algorithm takes into account all of ADC Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting ADC Therapeutics' buy or sell advice are summarized below:
Real Value 3.85 | Target Price 8.6 | Hype Value 4.97 | Market Value 4.78 | Naive Value 4.59 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell ADC Therapeutics SA given historical horizon and risk tolerance towards ADC Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for ADC Therapeutics SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
ADC |
Execute ADC Therapeutics Buy or Sell Advice
The ADC recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ADC Therapeutics SA. Macroaxis does not own or have any residual interests in ADC Therapeutics SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ADC Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Good | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
ADC Therapeutics Trading Alerts and Improvement Suggestions
| ADC Therapeutics is way too risky over 90 days horizon | |
| ADC Therapeutics appears to be risky and price may revert if volatility continues | |
| ADC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 69.56 M. Net Loss for the year was (240.05 M) with profit before overhead, payroll, taxes, and interest of 35.1 M. | |
| ADC Therapeutics SA currently holds about 376.78 M in cash with (118.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: ADC Therapeutics SA Receives Consensus Recommendation of Hold from Analysts - MarketBeat |
ADC Therapeutics Returns Distribution Density
The distribution of ADC Therapeutics' historical returns is an attempt to chart the uncertainty of ADC Therapeutics' future price movements. The chart of the probability distribution of ADC Therapeutics daily returns describes the distribution of returns around its average expected value. We use ADC Therapeutics SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ADC Therapeutics returns is essential to provide solid investment advice for ADC Therapeutics.
| Mean Return | 1.75 | Value At Risk | -7.49 | Potential Upside | 15.38 | Standard Deviation | 6.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ADC Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ADC Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ADC Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ADC Therapeutics SA backward and forwards among themselves. ADC Therapeutics' institutional investor refers to the entity that pools money to purchase ADC Therapeutics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jane Street Group, Llc | 2023-12-31 | 101.3 K | Indie Asset Partners, Llc | 2023-12-31 | 92.7 K | Miracle Mile Advisors, Inc. | 2023-12-31 | 84.5 K | Hrt Financial Llc | 2023-12-31 | 80.1 K | Hennion & Walsh Asset Management Inc | 2023-12-31 | 65.9 K | Magnetar Financial Llc | 2023-12-31 | 55.8 K | Xtx Topco Ltd | 2023-12-31 | 43.6 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 21.8 K | Susquehanna International Group, Llp | 2023-12-31 | 20.7 K | Prosight Management, Lp | 2023-12-31 | 6.5 M | Goldman Sachs Group Inc | 2023-12-31 | 2.9 M |
ADC Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ADC Therapeutics or Communications Equipment sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ADC Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ADC stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.39 | |
β | Beta against NYSE Composite | 4.08 | |
σ | Overall volatility | 6.36 | |
Ir | Information ratio | 0.24 |
ADC Therapeutics Volatility Alert
ADC Therapeutics SA is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ADC Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ADC Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ADC Therapeutics Fundamentals Vs Peers
Comparing ADC Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ADC Therapeutics' direct or indirect competition across all of the common fundamentals between ADC Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as ADC Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ADC Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing ADC Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ADC Therapeutics to competition |
| Fundamentals | ADC Therapeutics | Peer Average |
| Return On Equity | -7.06 | -0.31 |
| Return On Asset | -0.25 | -0.14 |
| Operating Margin | (2.22) % | (5.51) % |
| Current Valuation | 535.59 M | 16.62 B |
| Shares Outstanding | 82.53 M | 571.82 M |
| Shares Owned By Insiders | 29.00 % | 10.09 % |
| Shares Owned By Institutions | 41.17 % | 39.21 % |
| Number Of Shares Shorted | 993.08 K | 4.71 M |
| Price To Earning | 19.80 X | 28.72 X |
| Price To Book | 2.58 X | 9.51 X |
| Price To Sales | 5.21 X | 11.42 X |
| Revenue | 69.56 M | 9.43 B |
| Gross Profit | 35.1 M | 27.38 B |
| EBITDA | (145.78 M) | 3.9 B |
| Net Income | (240.05 M) | 570.98 M |
| Cash And Equivalents | 376.78 M | 2.7 B |
| Cash Per Share | 4.90 X | 5.01 X |
| Total Debt | 124.38 M | 5.32 B |
| Debt To Equity | 2.75 % | 48.70 % |
| Current Ratio | 5.76 X | 2.16 X |
| Book Value Per Share | (1.80) X | 1.93 K |
| Cash Flow From Operations | (118.69 M) | 971.22 M |
| Short Ratio | 1.74 X | 4.00 X |
| Earnings Per Share | (2.94) X | 3.12 X |
| Price To Earnings To Growth | 0.74 X | 4.89 X |
| Target Price | 10.2 | |
| Number Of Employees | 273 | 18.84 K |
| Beta | 1.74 | -0.15 |
| Market Capitalization | 410.17 M | 19.03 B |
| Total Asset | 354.78 M | 29.47 B |
| Retained Earnings | (1.34 B) | 9.33 B |
| Working Capital | 268.62 M | 1.48 B |
| Current Asset | 1.11 B | 9.34 B |
Note: ADC Therapeutics exotic insider transaction detected [view details]
ADC Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ADC . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 16040.07 | |||
| Daily Balance Of Power | (0.66) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 4.86 | |||
| Day Typical Price | 4.83 | |||
| Price Action Indicator | (0.17) | |||
| Period Momentum Indicator | (0.19) | |||
| Relative Strength Index | 24.77 |
About ADC Therapeutics Buy or Sell Advice
When is the right time to buy or sell ADC Therapeutics SA? Buying financial instruments such as ADC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 73.0M | 50.6M | 58.2M | 34.4M | Total Assets | 529.2M | 354.8M | 408.0M | 375.5M |
Use Investing Ideas to Build Portfolios
In addition to having ADC Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ADC Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the ADC Therapeutics information on this page should be used as a complementary analysis to other ADC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for ADC Stock analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is ADC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 0.851 | Quarterly Revenue Growth (0.76) | Return On Assets (0.25) | Return On Equity (7.06) |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.